U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Dexmedetomidine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 04/10/2020
»Therapeutic Categories: Anesthesia

Expand all

Accord Healthcare Inc. (Revised 05/06/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 ug/1 mL (NDC 16729-239-93) Unavailable Resupply TBD Requirements related to complying with good manufacturing practices
Injection, 100 ug/1 mL (NDC 16729-432-93) Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug

Amneal Pharmaceuticals (Revised 05/07/2024)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 4 ug/1 mL (NDC 70121-1388-8) Available
Injection, 4 ug/1 mL (NDC 70121-1389-7) Available
Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1) Available
Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) Available

Baxter Healthcare (Reverified 05/13/2024)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) Available
Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) Available
Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) Available
Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) Available

Eugia US LLC (Reverified 04/22/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) Available Check wholesalers for inventory
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) Available Check wholesalers for inventory
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) Available Check wholesalers for inventory

Fresenius Kabi USA, LLC (Revised 05/08/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 4 ug/1 mL (NDC 63323-671-20) Unavailable Next release not available at this time. Demand increase for the drug
Injection, 4 ug/1 mL (NDC 63323-671-50) Unavailable Not available at this time. Demand increase for the drug
Injection, 4 ug/1 mL (NDC 63323-671-00) Unavailable Not available at this time. Demand increase for the drug
Injection, 100 ug/1 mL (NDC 63323-421-02) Available Check wholesalers for inventory

Gland Pharma Limited (Revised 03/15/2024)

Company Contact Information:
866-733-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) Available
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) Available
Injection, 200 ug/2 mL (NDC 66794-230-42) Available Marketed by Piramal Critical Care Inc.: 800-414-1901

Hikma Pharmaceuticals USA, Inc. (Revised 05/07/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) Available Additional lots will be scheduled for manufacturing. Product will be made available as it is released.

HQ Specialty Pharma (Reverified 04/15/2024)

Company Contact Information:
WG Critical Care 888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 ug/1 mL (NDC 44567-600-04) Available Marketed by WG Critical Care
Injection, 100 ug/1 mL (NDC 44567-601-04) Available Marketed by WG Critical Care
Injection, 4 ug/1 mL (NDC 44567-602-24) Available Marketed by WG Critical Care
Injection, 4 ug/1 mL (NDC 44567-603-24) Available Marketed by WG Critical Care

Jiangsu Hengrui Medicine Co. Ltd. (Revised 01/15/2024)

Company Contact Information:
Athenex: 855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70860-605-03) Available

Meitheal Pharmaceuticals, Inc. (Reverified 04/24/2024)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03) Available Demand increase for the drug

Mylan Institutional, a Viatris Company (Reverified 04/16/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) Available
Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) Available
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) Available

Par Pharmaceutical, Inc. (Revised 05/15/2024)

Company Contact Information:
800-828-9393

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 ug/1 mL (NDC 42023-146-25) Available Please check wholesalers for inventory
Injection, 4 ug/1 mL (NDC 42023-186-20) Limited Availability Please check wholesalers for inventory Other
Injection, 4 ug/1 mL (NDC 42023-187-10) Limited Availability Please check wholesalers for inventory Other

Pfizer Inc. (Revised 05/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) Limited Availability Limited Supply Available. Next Delivery: June 2024; Estimated Recovery: September 2024 Demand increase for the drug
Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) Available
Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) Available
Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) Available

Slayback Pharma (Revised 01/15/2024)

Company Contact Information:
844-566-2505

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05) Available
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06) Available
Back to Top